Review





Similar Products

90
Santa Cruz Biotechnology cep55
Mutation of Ser91 to alanine does not impair INCENP-association with CPC proteins. (A) Frequency of midbody stage cells. BE cells were released from a prometaphase block and treated with 10 µM Chk2 inhibitor II (inhII) in cytokinesis, or left untreated. Values represent mean ± SD from three independent experiments ( n > 900). (B) Accumulation of dead BE cells with time as determined by trypan blue staining. Mean ± SD from three independent experiments ( n = 6). (A and B) ***, P < 0.001 (ANOVA and Student’s t test). (C, D, G, and H) Localization of Mklp2 or <t>Cep55</t> and mean intensity at the midbody or midbody center in BE cells. (E) GFP-Trap assay. BE cells were untransfected (untransf.) or transfected with GFP:INCENP. Precipitated (top) or total proteins (bottom) were analyzed by Western blotting. (F and L) Western blot analysis of total Cep55, ATM, actin and tubulin. (I) Total GFP and Mklp2 from . (J) Cartoon indicating the regions of human Mklp2 protein interacting with INCENP, Cep55 and myosin-II. Numbers show amino-acid residues. motor, kinesin motor domain. (K) Western blot analysis of total Mklp2 and actin in BE cells expressing GFP:Mklp2(ΔC90). (M) Specificity of the anti-phospho-ATM-Ser1981 (pATM-Ser1981) antibody. Tubulin values indicate midbody thickness. Insets show 1.6× magnification of the midbodies. (N and O) Phase-contrast live-cell microscopy analysis of HeLa tubulin:GFP cells treated with 10 µM KU-55933 in cytokinesis. Intercellular canals are shown by solid arrows. Time is from formation of an intercellular canal to canal cleavage (dotted arrows). Related to . Values represent mean ± SD from n cells. ***, P < 0.001 (Student’s t test). Scale bars, 5 µm. (P and Q) Frequency of prometaphase or bi/multinucleate BE cells. Values represent mean ± SD from three independent experiments ( n > 900). ns, not statistically significant. S, serine.
Cep55, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pmc07769160-218-89-121?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
cep55 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rabbit anti sumo 1 sumo
Mutation of Ser91 to alanine does not impair INCENP-association with CPC proteins. (A) Frequency of midbody stage cells. BE cells were released from a prometaphase block and treated with 10 µM Chk2 inhibitor II (inhII) in cytokinesis, or left untreated. Values represent mean ± SD from three independent experiments ( n > 900). (B) Accumulation of dead BE cells with time as determined by trypan blue staining. Mean ± SD from three independent experiments ( n = 6). (A and B) ***, P < 0.001 (ANOVA and Student’s t test). (C, D, G, and H) Localization of Mklp2 or <t>Cep55</t> and mean intensity at the midbody or midbody center in BE cells. (E) GFP-Trap assay. BE cells were untransfected (untransf.) or transfected with GFP:INCENP. Precipitated (top) or total proteins (bottom) were analyzed by Western blotting. (F and L) Western blot analysis of total Cep55, ATM, actin and tubulin. (I) Total GFP and Mklp2 from . (J) Cartoon indicating the regions of human Mklp2 protein interacting with INCENP, Cep55 and myosin-II. Numbers show amino-acid residues. motor, kinesin motor domain. (K) Western blot analysis of total Mklp2 and actin in BE cells expressing GFP:Mklp2(ΔC90). (M) Specificity of the anti-phospho-ATM-Ser1981 (pATM-Ser1981) antibody. Tubulin values indicate midbody thickness. Insets show 1.6× magnification of the midbodies. (N and O) Phase-contrast live-cell microscopy analysis of HeLa tubulin:GFP cells treated with 10 µM KU-55933 in cytokinesis. Intercellular canals are shown by solid arrows. Time is from formation of an intercellular canal to canal cleavage (dotted arrows). Related to . Values represent mean ± SD from n cells. ***, P < 0.001 (Student’s t test). Scale bars, 5 µm. (P and Q) Frequency of prometaphase or bi/multinucleate BE cells. Values represent mean ± SD from three independent experiments ( n > 900). ns, not statistically significant. S, serine.
Rabbit Anti Sumo 1 Sumo, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pmc05651848-184-23-27?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti sumo 1 sumo - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology sc 9060 wb
Mutation of Ser91 to alanine does not impair INCENP-association with CPC proteins. (A) Frequency of midbody stage cells. BE cells were released from a prometaphase block and treated with 10 µM Chk2 inhibitor II (inhII) in cytokinesis, or left untreated. Values represent mean ± SD from three independent experiments ( n > 900). (B) Accumulation of dead BE cells with time as determined by trypan blue staining. Mean ± SD from three independent experiments ( n = 6). (A and B) ***, P < 0.001 (ANOVA and Student’s t test). (C, D, G, and H) Localization of Mklp2 or <t>Cep55</t> and mean intensity at the midbody or midbody center in BE cells. (E) GFP-Trap assay. BE cells were untransfected (untransf.) or transfected with GFP:INCENP. Precipitated (top) or total proteins (bottom) were analyzed by Western blotting. (F and L) Western blot analysis of total Cep55, ATM, actin and tubulin. (I) Total GFP and Mklp2 from . (J) Cartoon indicating the regions of human Mklp2 protein interacting with INCENP, Cep55 and myosin-II. Numbers show amino-acid residues. motor, kinesin motor domain. (K) Western blot analysis of total Mklp2 and actin in BE cells expressing GFP:Mklp2(ΔC90). (M) Specificity of the anti-phospho-ATM-Ser1981 (pATM-Ser1981) antibody. Tubulin values indicate midbody thickness. Insets show 1.6× magnification of the midbodies. (N and O) Phase-contrast live-cell microscopy analysis of HeLa tubulin:GFP cells treated with 10 µM KU-55933 in cytokinesis. Intercellular canals are shown by solid arrows. Time is from formation of an intercellular canal to canal cleavage (dotted arrows). Related to . Values represent mean ± SD from n cells. ***, P < 0.001 (Student’s t test). Scale bars, 5 µm. (P and Q) Frequency of prometaphase or bi/multinucleate BE cells. Values represent mean ± SD from three independent experiments ( n > 900). ns, not statistically significant. S, serine.
Sc 9060 Wb, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pm28127275-114-48-68?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
sc 9060 wb - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology cep55 sirna
<t>CEP55</t> expression is upregulated in glioma. (A) The levels of CEP55 mRNA expression in glioma tissue samples (7 astrocytomas grade II, 19 astrocytomas grade III, 81 glioblastoma, 38 oligodendrogliomas grade II and 12 oligodendrogliomas grade III samples) compared to those in 23 non-tumor samples in microarray database (GDS1962 / 218542_at / CEP55, p < 0.01). (B) mRNA levels of CEP55 as determined by qRT-PCR analysis in 14 glioma grade II and 31 grade III-IV tissue samples compared to those in 5 non-tumor brain tissue samples ( p < 0.01). (C) Representative immunohistochemical staining of CEP55 in non-tumor, glioma grade II and grade III-IV samples.
Cep55 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pmc04964127-52-0-8?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
cep55 sirna - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology sc 9060 santa cruz anti pax7 ms igg1
<t>CEP55</t> expression is upregulated in glioma. (A) The levels of CEP55 mRNA expression in glioma tissue samples (7 astrocytomas grade II, 19 astrocytomas grade III, 81 glioblastoma, 38 oligodendrogliomas grade II and 12 oligodendrogliomas grade III samples) compared to those in 23 non-tumor samples in microarray database (GDS1962 / 218542_at / CEP55, p < 0.01). (B) mRNA levels of CEP55 as determined by qRT-PCR analysis in 14 glioma grade II and 31 grade III-IV tissue samples compared to those in 5 non-tumor brain tissue samples ( p < 0.01). (C) Representative immunohistochemical staining of CEP55 in non-tumor, glioma grade II and grade III-IV samples.
Sc 9060 Santa Cruz Anti Pax7 Ms Igg1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pm23247248-80-43-44?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
sc 9060 santa cruz anti pax7 ms igg1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology sumo1 fl 101
Antibody information.
Sumo1 Fl 101, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pmc03199210-23-0-3?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
sumo1 fl 101 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology sc 9060
Antibody information.
Sc 9060, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pmc03199210-23-7-3?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
sc 9060 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology polyclonal rabbit anti sumo 1
Antibody information.
Polyclonal Rabbit Anti Sumo 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pm18331345-219-20-27?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
polyclonal rabbit anti sumo 1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rabbit anti sumo 1
Antibody information.
Rabbit Anti Sumo 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/pm16735446-285-5-33?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti sumo 1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology anti sumo 1
Antibody information.
Anti Sumo 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/90601/10__1074_slash_jbc__m600852200-58-4-26?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
anti sumo 1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Mutation of Ser91 to alanine does not impair INCENP-association with CPC proteins. (A) Frequency of midbody stage cells. BE cells were released from a prometaphase block and treated with 10 µM Chk2 inhibitor II (inhII) in cytokinesis, or left untreated. Values represent mean ± SD from three independent experiments ( n > 900). (B) Accumulation of dead BE cells with time as determined by trypan blue staining. Mean ± SD from three independent experiments ( n = 6). (A and B) ***, P < 0.001 (ANOVA and Student’s t test). (C, D, G, and H) Localization of Mklp2 or Cep55 and mean intensity at the midbody or midbody center in BE cells. (E) GFP-Trap assay. BE cells were untransfected (untransf.) or transfected with GFP:INCENP. Precipitated (top) or total proteins (bottom) were analyzed by Western blotting. (F and L) Western blot analysis of total Cep55, ATM, actin and tubulin. (I) Total GFP and Mklp2 from . (J) Cartoon indicating the regions of human Mklp2 protein interacting with INCENP, Cep55 and myosin-II. Numbers show amino-acid residues. motor, kinesin motor domain. (K) Western blot analysis of total Mklp2 and actin in BE cells expressing GFP:Mklp2(ΔC90). (M) Specificity of the anti-phospho-ATM-Ser1981 (pATM-Ser1981) antibody. Tubulin values indicate midbody thickness. Insets show 1.6× magnification of the midbodies. (N and O) Phase-contrast live-cell microscopy analysis of HeLa tubulin:GFP cells treated with 10 µM KU-55933 in cytokinesis. Intercellular canals are shown by solid arrows. Time is from formation of an intercellular canal to canal cleavage (dotted arrows). Related to . Values represent mean ± SD from n cells. ***, P < 0.001 (Student’s t test). Scale bars, 5 µm. (P and Q) Frequency of prometaphase or bi/multinucleate BE cells. Values represent mean ± SD from three independent experiments ( n > 900). ns, not statistically significant. S, serine.

Journal: The Journal of Cell Biology

Article Title: An ATM–Chk2–INCENP pathway activates the abscission checkpoint

doi: 10.1083/jcb.202008029

Figure Lengend Snippet: Mutation of Ser91 to alanine does not impair INCENP-association with CPC proteins. (A) Frequency of midbody stage cells. BE cells were released from a prometaphase block and treated with 10 µM Chk2 inhibitor II (inhII) in cytokinesis, or left untreated. Values represent mean ± SD from three independent experiments ( n > 900). (B) Accumulation of dead BE cells with time as determined by trypan blue staining. Mean ± SD from three independent experiments ( n = 6). (A and B) ***, P < 0.001 (ANOVA and Student’s t test). (C, D, G, and H) Localization of Mklp2 or Cep55 and mean intensity at the midbody or midbody center in BE cells. (E) GFP-Trap assay. BE cells were untransfected (untransf.) or transfected with GFP:INCENP. Precipitated (top) or total proteins (bottom) were analyzed by Western blotting. (F and L) Western blot analysis of total Cep55, ATM, actin and tubulin. (I) Total GFP and Mklp2 from . (J) Cartoon indicating the regions of human Mklp2 protein interacting with INCENP, Cep55 and myosin-II. Numbers show amino-acid residues. motor, kinesin motor domain. (K) Western blot analysis of total Mklp2 and actin in BE cells expressing GFP:Mklp2(ΔC90). (M) Specificity of the anti-phospho-ATM-Ser1981 (pATM-Ser1981) antibody. Tubulin values indicate midbody thickness. Insets show 1.6× magnification of the midbodies. (N and O) Phase-contrast live-cell microscopy analysis of HeLa tubulin:GFP cells treated with 10 µM KU-55933 in cytokinesis. Intercellular canals are shown by solid arrows. Time is from formation of an intercellular canal to canal cleavage (dotted arrows). Related to . Values represent mean ± SD from n cells. ***, P < 0.001 (Student’s t test). Scale bars, 5 µm. (P and Q) Frequency of prometaphase or bi/multinucleate BE cells. Values represent mean ± SD from three independent experiments ( n > 900). ns, not statistically significant. S, serine.

Article Snippet: Human Mre11 (a pool of three different siRNAs: 5′-CAG AAC AGA UGG CUA AUG A-3′, 5′-GUG AGG GAA UGG UCA CUA A-3′, and 5′-GUA GGG AAU UCU UCU GUU A-3′), ATM (a pool of three different siRNAs: 5′-GUA GCA ACA UAC UAC UCA A-3′, 5′-GCA ACA UAC UAC UCA AAG A-3′, and 5′-GCA ACC CAA UUA AUA UCA A-3′), Rad50 (a pool of three different siRNAs: 5′-CAA GGU UGC UCA AGA AAC A-3′, 5′-CCA ACC AAC UGA UGA AUG A-3′, and 5′-CAA CAG AAC UUG UGA ACA A-3′), and Cep55 (a pool of three different siRNAs: 5′-CUA CCG CAU UGC UUG AAC A-3′, 5′-CAG GUC CAG UUU CUU UAC A-3′, and 5′-GCA UGC UAG UGA AUC AUG U-3′) siRNAs were from Santa Cruz Biotechnology.

Techniques: Mutagenesis, Blocking Assay, Staining, TRAP Assay, Transfection, Western Blot, Expressing, Microscopy

GFP:INCENP binds to GST-Cep55 through Mklp2. (A) GFP-Trap kinase assay from BE cell extracts using histone H3 as substrate. GFP-associated histone H3-Ser10 phosphorylation (pH3-Ser10), immunoprecipitated Aurora B, and GFP were analyzed by Western blotting. Histone H3 was analyzed by Ponceau staining. 300 nM VX-680 was added to the kinase reaction to inhibit Aurora B catalytic activity. (B) Cep55:GFP colocalizes with INCENP at the midbody center in BE cells. (C–F) Localization and mean intensity of INCENP at the midbody or midbody center in BE cells. Mean ± SD from n cells. Values in control were set to 1. ***, P < 0.001 (Student’s t test). Tubulin values indicate midbody thickness. Insets show 1.6× magnification of the midbodies. Scale bars, 5 µm. (G) Immunoprecipitation from cytokinesis-enriched BE cell extracts. (H) Predicted experimental outcome. In the Western blot, the width of the lines indicates band signals intensity. (I and J) Cell lysates from BE cells were incubated with GST-Cep55 or GST. Associated proteins were detected by Western blotting. (K and N) Radiolabeled FL or truncated Mklp2 (ΔC90) was incubated with GST-Cep55 or GST. Phosphorimager ( 35 S, top) and Western blot analysis (WB; bottom) of the same gel. Asterisks, predicted molecular weights. (L and M) GFP-Trap assay. Precipitated (L) or input proteins (M) were analyzed by Western blotting. S, serine.

Journal: The Journal of Cell Biology

Article Title: An ATM–Chk2–INCENP pathway activates the abscission checkpoint

doi: 10.1083/jcb.202008029

Figure Lengend Snippet: GFP:INCENP binds to GST-Cep55 through Mklp2. (A) GFP-Trap kinase assay from BE cell extracts using histone H3 as substrate. GFP-associated histone H3-Ser10 phosphorylation (pH3-Ser10), immunoprecipitated Aurora B, and GFP were analyzed by Western blotting. Histone H3 was analyzed by Ponceau staining. 300 nM VX-680 was added to the kinase reaction to inhibit Aurora B catalytic activity. (B) Cep55:GFP colocalizes with INCENP at the midbody center in BE cells. (C–F) Localization and mean intensity of INCENP at the midbody or midbody center in BE cells. Mean ± SD from n cells. Values in control were set to 1. ***, P < 0.001 (Student’s t test). Tubulin values indicate midbody thickness. Insets show 1.6× magnification of the midbodies. Scale bars, 5 µm. (G) Immunoprecipitation from cytokinesis-enriched BE cell extracts. (H) Predicted experimental outcome. In the Western blot, the width of the lines indicates band signals intensity. (I and J) Cell lysates from BE cells were incubated with GST-Cep55 or GST. Associated proteins were detected by Western blotting. (K and N) Radiolabeled FL or truncated Mklp2 (ΔC90) was incubated with GST-Cep55 or GST. Phosphorimager ( 35 S, top) and Western blot analysis (WB; bottom) of the same gel. Asterisks, predicted molecular weights. (L and M) GFP-Trap assay. Precipitated (L) or input proteins (M) were analyzed by Western blotting. S, serine.

Article Snippet: Human Mre11 (a pool of three different siRNAs: 5′-CAG AAC AGA UGG CUA AUG A-3′, 5′-GUG AGG GAA UGG UCA CUA A-3′, and 5′-GUA GGG AAU UCU UCU GUU A-3′), ATM (a pool of three different siRNAs: 5′-GUA GCA ACA UAC UAC UCA A-3′, 5′-GCA ACA UAC UAC UCA AAG A-3′, and 5′-GCA ACC CAA UUA AUA UCA A-3′), Rad50 (a pool of three different siRNAs: 5′-CAA GGU UGC UCA AGA AAC A-3′, 5′-CCA ACC AAC UGA UGA AUG A-3′, and 5′-CAA CAG AAC UUG UGA ACA A-3′), and Cep55 (a pool of three different siRNAs: 5′-CUA CCG CAU UGC UUG AAC A-3′, 5′-CAG GUC CAG UUU CUU UAC A-3′, and 5′-GCA UGC UAG UGA AUC AUG U-3′) siRNAs were from Santa Cruz Biotechnology.

Techniques: Kinase Assay, Phospho-proteomics, Immunoprecipitation, Western Blot, Staining, Activity Assay, Control, Incubation, TRAP Assay

CEP55 expression is upregulated in glioma. (A) The levels of CEP55 mRNA expression in glioma tissue samples (7 astrocytomas grade II, 19 astrocytomas grade III, 81 glioblastoma, 38 oligodendrogliomas grade II and 12 oligodendrogliomas grade III samples) compared to those in 23 non-tumor samples in microarray database (GDS1962 / 218542_at / CEP55, p < 0.01). (B) mRNA levels of CEP55 as determined by qRT-PCR analysis in 14 glioma grade II and 31 grade III-IV tissue samples compared to those in 5 non-tumor brain tissue samples ( p < 0.01). (C) Representative immunohistochemical staining of CEP55 in non-tumor, glioma grade II and grade III-IV samples.

Journal: Journal of Cancer

Article Title: Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway

doi: 10.7150/jca.15497

Figure Lengend Snippet: CEP55 expression is upregulated in glioma. (A) The levels of CEP55 mRNA expression in glioma tissue samples (7 astrocytomas grade II, 19 astrocytomas grade III, 81 glioblastoma, 38 oligodendrogliomas grade II and 12 oligodendrogliomas grade III samples) compared to those in 23 non-tumor samples in microarray database (GDS1962 / 218542_at / CEP55, p < 0.01). (B) mRNA levels of CEP55 as determined by qRT-PCR analysis in 14 glioma grade II and 31 grade III-IV tissue samples compared to those in 5 non-tumor brain tissue samples ( p < 0.01). (C) Representative immunohistochemical staining of CEP55 in non-tumor, glioma grade II and grade III-IV samples.

Article Snippet: CEP55 siRNA and scrambled siRNA were purchased from Santa Cruz.

Techniques: Expressing, Microarray, Quantitative RT-PCR, Immunohistochemical staining, Staining

CEP55 regulates glioma cell glucose metabolism. (A) Protein levels of CEP55 as determined by Western blot analysis in U87 and T98G cells treated with the indicated concentrations of glucose (0, 1, 5, 10 or 20 mM). GAPDH was used as the loading control. (B) Protein levels of CEP55 as determined by Western blot analysis in U87 and T98G cells treated with 5 mM glucose for the indicated time periods (0, 4, 8, 12 or 24 h). (C) Protein levels of CEP55 and GLUT1 in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (D) Relative glucose uptake in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55 and treated with the indicated concentrations of glucose (0, 5, or 20 mM). * p < 0.5 compared to cells treated with 0 mM glucose, # p < 0.05 compared to control siRNA transfected cells treated with the same glucose concentration.

Journal: Journal of Cancer

Article Title: Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway

doi: 10.7150/jca.15497

Figure Lengend Snippet: CEP55 regulates glioma cell glucose metabolism. (A) Protein levels of CEP55 as determined by Western blot analysis in U87 and T98G cells treated with the indicated concentrations of glucose (0, 1, 5, 10 or 20 mM). GAPDH was used as the loading control. (B) Protein levels of CEP55 as determined by Western blot analysis in U87 and T98G cells treated with 5 mM glucose for the indicated time periods (0, 4, 8, 12 or 24 h). (C) Protein levels of CEP55 and GLUT1 in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (D) Relative glucose uptake in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55 and treated with the indicated concentrations of glucose (0, 5, or 20 mM). * p < 0.5 compared to cells treated with 0 mM glucose, # p < 0.05 compared to control siRNA transfected cells treated with the same glucose concentration.

Article Snippet: CEP55 siRNA and scrambled siRNA were purchased from Santa Cruz.

Techniques: Western Blot, Control, Transfection, Concentration Assay

Knockdown of CEP55 inhibits glioma cell proliferation. (A) Cell proliferation rates as determined by MTS assay in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (B) Cell proliferation rates as determined by CCK-8 assay in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (C) BrdU staining and quantification in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. * p < 0.5 compared to control siRNA transfected cells.

Journal: Journal of Cancer

Article Title: Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway

doi: 10.7150/jca.15497

Figure Lengend Snippet: Knockdown of CEP55 inhibits glioma cell proliferation. (A) Cell proliferation rates as determined by MTS assay in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (B) Cell proliferation rates as determined by CCK-8 assay in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (C) BrdU staining and quantification in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. * p < 0.5 compared to control siRNA transfected cells.

Article Snippet: CEP55 siRNA and scrambled siRNA were purchased from Santa Cruz.

Techniques: Knockdown, MTS Assay, Transfection, Control, CCK-8 Assay, BrdU Staining

Knockdown of CEP55 induces glioma cell apoptosis. (A) Cell viability assay in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (B) Caspase-3 activity assay in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (C) TUNEL staining and quantification in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. * p < 0.5 compared to control siRNA transfected cells.

Journal: Journal of Cancer

Article Title: Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway

doi: 10.7150/jca.15497

Figure Lengend Snippet: Knockdown of CEP55 induces glioma cell apoptosis. (A) Cell viability assay in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (B) Caspase-3 activity assay in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. (C) TUNEL staining and quantification in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. * p < 0.5 compared to control siRNA transfected cells.

Article Snippet: CEP55 siRNA and scrambled siRNA were purchased from Santa Cruz.

Techniques: Knockdown, Viability Assay, Transfection, Control, Caspase-3 Activity Assay, TUNEL Assay, Staining

Clinicopathological characteristics of patients and expression of  CEP55  in glioma.

Journal: Journal of Cancer

Article Title: Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway

doi: 10.7150/jca.15497

Figure Lengend Snippet: Clinicopathological characteristics of patients and expression of CEP55 in glioma.

Article Snippet: CEP55 siRNA and scrambled siRNA were purchased from Santa Cruz.

Techniques: Expressing, Histopathology

CEP55 regulates the Akt/mTOR signaling pathway. (A) Protein levels of p-Akt, total Akt, p-mTOR and total mTOR as determined by Western blot analysis in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. GAPDH was used as the loading control. (B) Protein levels of Akt downstream targets (BAD, Caspase-9, p27 and GSK-3β) as determined by Western blot analysis in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55.

Journal: Journal of Cancer

Article Title: Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway

doi: 10.7150/jca.15497

Figure Lengend Snippet: CEP55 regulates the Akt/mTOR signaling pathway. (A) Protein levels of p-Akt, total Akt, p-mTOR and total mTOR as determined by Western blot analysis in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55. GAPDH was used as the loading control. (B) Protein levels of Akt downstream targets (BAD, Caspase-9, p27 and GSK-3β) as determined by Western blot analysis in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55.

Article Snippet: CEP55 siRNA and scrambled siRNA were purchased from Santa Cruz.

Techniques: Western Blot, Transfection, Control

Knockdown of CEP55 inhibits glioma development via suppressing Akt/mTOR signaling. (A) Relative glucose uptake, (B) cell proliferation and (C) cell viability in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55 treated with or without Akt inhibitor MK-2206 or mTOR inhibitor rapamycin.

Journal: Journal of Cancer

Article Title: Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway

doi: 10.7150/jca.15497

Figure Lengend Snippet: Knockdown of CEP55 inhibits glioma development via suppressing Akt/mTOR signaling. (A) Relative glucose uptake, (B) cell proliferation and (C) cell viability in U87 and T98G cells transfected with control siRNA or siRNA targeting CEP55 treated with or without Akt inhibitor MK-2206 or mTOR inhibitor rapamycin.

Article Snippet: CEP55 siRNA and scrambled siRNA were purchased from Santa Cruz.

Techniques: Knockdown, Transfection, Control

Antibody information.

Journal: Journal of Biomedicine and Biotechnology

Article Title: Possible Linkage of SP6 Transcriptional Activity with Amelogenesis by Protein Stabilization

doi: 10.1155/2011/320987

Figure Lengend Snippet: Antibody information.

Article Snippet: Sumo1 (FL-101) , Santa Cruz biotechnology , sc-9060 , 1 : 1000 , —.

Techniques: Ubiquitin Proteomics